HOXA13 and acute lymphoblastic leukemia: Among those, JAK-STAT-signaling and TP53 pathway were altered in HOXA13 compared to HOXA (Fig. 3C), which have been associated with poor prognosis (TP53) and association to the unfavorable immunophenotype of early T-ALL (JAK/STAT mutations).